This is particularly evident for Ras-driven lung cancers, where ATG7 deletion results in increased mitochondrial mutation load, impaired mitochondrial function, increased production of reactive oxygen species, and a reduction in the cellular nucleotide pool [91]. This evidence concerns the gene ATG7 and lung carcinoma.